When Immunodeficiency Meets Neurosurgery: Brain Abscess in a Wiskott-Aldrich Syndrome Patient
Keywords:
Wiskott-Aldrich Syndrome, Brain Abscess, Primary Immunodeficiency DiseasesAbstract
CASE REPORT: A 4-year-old male with a known diagnosis of WAS,presented with a sudden onset of abnormal behavior and left-sided eye and upper limb twitching that lasted around 15 minutes. These movements were not associated with loss of consciousness, tonic-clonic activity, frothing, tongue biting, or incontinence. The mother reported no fever, and there were no obvious infective foci identified. Notably, the child had a recent history of generalized eczema that had been infected and treated at a local hospital, and he had experienced multiple past episodes of eczema infected with methicillin-resistant Staphylococcus aureus (MRSA). On examination, the patient was clinically well and afebrile, with no apparent neurological deficits. He was alert and active, with healed eczematous rashes noted over the body. Other systemic examinations were unremarkable. Given the abnormal behavior and history of thrombocytopenia, a non-contrast CT (NCCT) of the brain was performed to rule out trauma or intracranial hemorrhage. The NCCT revealed a focal lesion with ring enhancement in the right hemisphere, consistent with a brain abscess. Blood cultures returned positive for MRSA, although inflammatory markers were only mildly elevated (CRP: 25 mg/L, leukocytes: 13.71 x 10^9/L). The patient was promptly optimized for neurosurgery with platelet transfusion and intravenous immunoglobulin (IVIG). A neurosurgical team performed burr hole drainage of the brain abscess, and high-dose intravenous antibiotics, including cefotaxime, metronidazole, and vancomycin, were initiated. The pus culture confirmed the presence of MRSA. Despite clinical improvement, the patient experienced two episodes of focal neurological seizures, prompting the initiation of prophylactic anticonvulsant therapy to prevent further seizures.
CONCLUSION: Brain abscesses are a rare but serious complication in patients with Wiskott-Aldrich Syndrome, highlighting the complexity of managing CNS infections in immunocompromised individuals. Early recognition and aggressive management, including prompt imaging, targeted microbiological analysis, and a multidisciplinary approach, are crucial for improving outcomes. This case underscores the necessity of maintaining a high index of suspicion for CNS infections in patients with WAS,especially when neurological symptoms are present. The successful management of this case demonstrates the importance of early intervention and tailored antibiotic therapy in achieving a favorable outcome, even in the context of severe underlying immunodeficiency.
Metrics
References
Blundell MP, Worth A, Bouma G, Thrasher AJ. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function. Dis Markers. 2010;29(3-4):157-75
Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2013 May;1285:26-43. doi: 10.1111/nyas.12049. Epub 2013 Mar 25. PMID: 23527602.
Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006 Apr;117(4):725-38; quiz 739. doi: 10.1016/j.jaci.2006.02.005. PMID: 16630926.
Chandra S, Nagaraj CB, Sun M, Chandrakasan S, Zhang K. WAS-Related Disorders. 2004 Sep 30 [updated 2024 Aug 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301357.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Kalhara, Pathirana NPNB
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org